The Plasmodium falciparum Erythrocyte Invasion Ligand Pfrh4 as a Target of Functional and Protective Human Antibodies against Malaria

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Reiling, Linda ^a,b   Richards, Jack S ^a,b,d   Fowkes, Freya J I ^a,b,h   Wilson, Danny W ^b   Chokejindachai, Watcharee ^c   Barry, Alyssa E ^a,b   Tham, Wai Hong ^b,d   Stubbs, Janine ^a   Langer, Christine ^a,b   Donelson, John ^e   Michon, Pascal ^f   Tavul, Livingstone ^f   Crabb, Brendan S ^a   Siba, Peter M ^f   Cowman, Alan F ^b   Mueller, Ivo ^b,f,g   Beeson, James G ^a,b  

^a BURNET INSTITUTE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF IOWA   (United States)

^f PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^g CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MEMBRANE PROTEIN; PLASMODIUM FALCIPARUM RETICULOCYTE BINDING HOMOLOG 4; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; CELL INVASION; CHILD; CONTROLLED STUDY; DENSITOMETRY; ERYTHROCYTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALARIA; NUCLEOTIDE SEQUENCE; OPSONIZATION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION; PROTEIN TARGETING; SCHOOL CHILD;

ADOLESCENT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MEMBRANE PROTEINS; MEROZOITES; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 84866706141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045253     Document Type: Article

References (54)

1. Elliott SR, Beeson J, (2008) Estimating the burden of global mortality in children aged <5 years by pathogen-specific causes. Clin Infect Dis 46: 1794-1795.
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
3. Cowman A, Crabb B, (2006) Invasion of red blood cells by malaria parasites. Cell 124: 755-766.
4. Gaur D, Mayer DC, Miller LH, (2004) Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol 34: 1413-1429.
5. Duraisingh M, Triglia T, Ralph SA, Rayner JC, Barnwell JW, et al. (2003) Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J 22: 1047-1057.
6. Stubbs J, Simpson K, Triglia T, Plouffe D, Tonkin C, et al. (2005) Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309: 1384-1387.
7. Persson K, Mccallum F, Reiling L, Lister N, Stubbs J, et al. (2008) Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 118: 342-351.
8. Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW, (2001) A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J Exp Med 194: 1571-1581.
9. Rayner JC, Galinski MR, Ingravallo P, Barnwell JW, (2000) Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc Natl Acad Sci USA 97: 9648-9653.
10. Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, et al. (2008) Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4: 40-51.
11. Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, et al. (2006) Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Molec Biochem Parasitol 145: 205-215.
12. Tham WH, Wilson DW, Lopaticki S, Schmidt CQ, Tetteh-Quarcoo PB, et al. (2010) Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci USA 107: 17327-17332.
13. Gaur D, Singh S, Singh S, Jiang L, Diouf A, et al. (2007) Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion. Proc Natl Acad Sci USA 104: 17789-17794.
14. Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH, (1994) Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264: 1941-1944.
15. Triglia T, Duraisingh M, Good R, Cowman A, (2005) Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol Microbiol 55: 162-174.
16. Mayer DC, Kaneko O, Hudson-Taylor DE, Reid ME, Miller LH, (2001) Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175. Proc Natl Acad Sci U S A 98: 5222-5227.
17. Thompson JK, Triglia T, Reed MB, Cowman AF, (2001) A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Molec Microbiol 41: 47-58.
18. Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, et al. (2003) A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem 278: 14480-14486.
19. Nery S, Deans AM, Mosobo M, Marsh K, Rowe JA, et al. (2006) Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. Molec Biochem Parasitol 149: 208-215.
20. Gomez-Escobar N, Amambua-Ngwa A, Walther M, Okebe J, Ebonyi A, et al. (2010) Erythrocyte Invasion and Merozoite Ligand Gene Expression in Severe and MildPlasmodium falciparumMalaria. J infect Dis 201: 444-452.
21. Tham WH, Schmidt CQ, Hauhart RE, Guariento M, Tetteh-Quarcoo PB, et al. (2011) Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood 118: 1923-1933.
22. Fowkes FJ, Richards JS, Simpson JA, Beeson J, (2010) The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. Plos Med 7: e1000218.
23. Richards JS, Beeson J, (2009) The future for blood-stage vaccines against malaria. Immunol Cell Biol 87: 377-390.
24. Langhorne J, Ndungu F, Sponaas A, Marsh K, (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732.
25. Stanisic D, Richards J, Mccallum F, Michon P, King C, et al. (2009) Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness. Infect Immun 77: 1165-1174.
26. Cohen S, Butcher GA, Crandall RB, (1969) Action of malarial antibody in vitro. Nature 223: 368-371.
27. Mccallum F, Persson KE, Mugyenyi CK, Fowkes FJ, Simpson JA, et al. (2008) Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum. PLoS ONE 3: e3571.
28. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P, (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172: 1633-1641.
29. Kumaratilake LM, Ferrante A, Jaeger T, Rzepczyk CM, (1992) Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect Immun 60: 3731-3738.
30. Reiling L, Richards JS, Fowkes FJ, Barry AE, Triglia T, et al. (2010) Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J Immunol 185: 6157-6167.
31. Richards JS, Stanisic DI, Fowkes FJ, Tavul L, Dabod E, et al. (2010) Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis 51: e50-60.
32. Tham WH, Wilson D, Reiling L, Chen L, Beeson J, et al. (2009) Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect Immun 77: 2427-2435.
33. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, et al. (2007) The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76: 997-1008.
34. Lin E, Tavul L, Michon P, Richards JS, Dabod E, et al. (2010) Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in Papua New Guinean school children. Am J Trop Med Hyg 83: 828-833.
35. Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, et al. (2004) Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23: 718-728.
36. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, et al. (2009) Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 77: 3033-3043.
37. Beeson J, Mann EJ, Byrne TJ, Caragounis A, Elliott SR, et al. (2006) Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J Infect Dis 193: 721-730.
38. Hommel M, Elliott S, Soma V, Kelly G, Fowkes F, et al. (2010) Evaluating the antigenic diversity of placental binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect Immun: 1-45.
39. Persson KE, Lee CT, Marsh K, Beeson J, (2006) Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J Clin Microbiol 44: 1665-1673.
40. Wilson DW, Crabb BS, Beeson JG, (2010) Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays. Malaria J 9: 152.
41. Reeder JC, Wapling J, Mueller I, Siba PM, Barry AE, (2011) Population genetic analysis of the Plasmodium falciparum 6-cys protein Pf38 in Papua New Guinea reveals domain-specific balancing selection. Malaria J 10: 126.
42. Schultz L, Wapling J, Mueller I, Ntsuke PO, Senn N, et al. (2010) Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Malar J 9: 336.
43. Nimmerjahn F, Ravetch JV, (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
44. Tetteh KK, Stewart LB, Ochola LI, Amambua-Ngwa A, Thomas AW, et al. (2009) Prospective identification of malaria parasite genes under balancing selection. PLoS One 4: e5568.
45. Roussilhon C, Oeuvray C, Muller-Graf C, Tall A, Rogier C, et al. (2007) Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 4: e320.
46. Wiener E, Atwal A, Thompson KM, Melamed MD, Gorick B, et al. (1987) Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages. Immunology 62: 401-404.
47. Hodder AN, Crewther PE, Anders RF, (2001) Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 69: 3286-3294.
48. Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, et al. (2009) Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay. Clin Vaccine Immunol 16: 963-968.
49. Wilson DW, Fowkes FJ, Gilson PR, Elliott SR, Tavul L, et al. (2011) Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans. PLoS One 6: e27705.
50. Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, et al. (2011) Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 6: e17102.
51. Triglia T, Chen L, Lopaticki S, Dekiwadia C, Riglar DT, et al. (2011) Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains. PLoS Pathog 7: e1002075.
52. Lopaticki S, Maier AG, Thompson J, Wilson DW, Tham WH, et al. (2011) Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect Immun 79: 1107-1117.
53. Baum J, Chen L, Healer J, Lopaticki S, Boyle M, et al. (2009) Reticulocyte-binding protein homologue 5- an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Intl J Parasitol 39: 371-380.
54. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, et al. (2011) The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2: 601.